CLAIMA, INC. – Trademark Portfolio

Entity Type: 03

CLAIMA, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CLAIMA STORIES. The owner is based in Portland, OR.

Portland, OR 97232

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CLAIMA
CLAIMA
Abandoned 2021
CLAIMA
CLAIMA
Abandoned 2021
CLAIMA
CLAIMA
Abandoned 2021

Trademark Classifications

CLAIMA, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (3 filings)

Clothing, footwear, headgear

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does CLAIMA, INC. have?

CLAIMA, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned.

What trademark classes does CLAIMA, INC. file in?

CLAIMA, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 25 covers clothing, footwear, headgear.

What are CLAIMA, INC.'s most well-known trademarks?

CLAIMA, INC.'s registered trademark portfolio includes well-known marks such as CLAIMA STORIES. These are among 1 currently registered trademark in the portfolio.

What is CLAIMA, INC.'s trademark registration success rate?

CLAIMA, INC. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.